The primary objective of this study was to evaluate the risk of coronary heart disease (CHD) correlated to total homocysteine (tHcy) levels among Hispanics (25.6%) and non-Hispanic whites (74.4%) with type-2 diabetes. The charts of 39 subjects with type-2 diabetes were selected from one physician’s caseload for a convenience sample. This endocrinologist has been supplementing his patients with 1-3 mg of folic acid daily if their tHcy levels were > 13 pmol/L. We found a significant difference (p < .001) between tHcy levels at baseline, follow-up I and follow-up II with a mean total reduction of 4 pmol/L.
The results indicated that tHcy levels could be reduced by 1-2 mg folic acid daily in 2-8 months in subjects with type-2 diabetes. The recommendation generated from this study’s findings is that a folic acid supplement be consumed as part of a long-term management regimen for type-2 diabetics.
Identifer | oai:union.ndltd.org:fiu.edu/oai:digitalcommons.fiu.edu:etd-4563 |
Date | 02 April 2003 |
Creators | Fondren, Casie L. |
Publisher | FIU Digital Commons |
Source Sets | Florida International University |
Detected Language | English |
Type | text |
Format | application/pdf |
Source | FIU Electronic Theses and Dissertations |
Page generated in 0.0018 seconds